Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) EBT (2016 - 2025)

Nutex Health's EBT history spans 16 years, with the latest figure at $25.9 million for Q4 2025.

  • For Q4 2025, EBT fell 76.17% year-over-year to $25.9 million; the TTM value through Dec 2025 reached $244.8 million, up 122.88%, while the annual FY2025 figure was $244.8 million, 122.88% up from the prior year.
  • EBT for Q4 2025 was $25.9 million at Nutex Health, down from $132.4 million in the prior quarter.
  • Across five years, EBT topped out at $132.4 million in Q3 2025 and bottomed at -$431.5 million in Q3 2022.
  • The 5-year median for EBT is -$1.4 million (2024), against an average of -$1.6 million.
  • The largest annual shift saw EBT crashed 1326.73% in 2021 before it skyrocketed 41392.11% in 2025.
  • A 5-year view of EBT shows it stood at $13.3 million in 2021, then tumbled by 166.33% to -$8.9 million in 2022, then tumbled by 246.87% to -$30.7 million in 2023, then skyrocketed by 453.81% to $108.7 million in 2024, then tumbled by 76.17% to $25.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's EBT are $25.9 million (Q4 2025), $132.4 million (Q3 2025), and $23.7 million (Q2 2025).